CUE

Cue Biopharma, Inc. CUE

CUE
Cue Biopharma, Inc. GANX
Gain Therapeutics, Inc. ATYR
aTyr Pharma, Inc. INAB
IN8bio, Inc. LTRN
Lantern Pharma Inc. MRSN
Mersana Therapeutics, Inc. CRNX
Crinetics Pharmaceuticals, Inc. SRRK
Scholar Rock Holding Corporation TECX
Tectonic Therapeutic, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CUE GANX ATYR INAB LTRN MRSN CRNX SRRK TECX
6M 3.84 % 17.26 % -64.31 % -53.95 % 35.20 % 18.77 % 54.35 % 40.93 % -0.87 %
YTD -27.02 % -15.09 % -72.89 % -75.03 % 31.52 % -73.60 % -12.84 % -10.64 % -64.94 %
1Y -34.26 % -16.17 % -52.68 % -69.16 % 22.25 % -82.06 % -15.39 % 38.36 % -52.53 %
3Y -73.66 % -38.24 % -38.73 % -96.37 % -8.63 % -94.59 % 151.71 % 431.81 % 122.50 %
5Y -95.05 % -82.41 % -38.73 % -99.30 % -77.41 % -98.08 % 177.86 % 162.19 % -91.18 %
10Y -93.16 % -82.41 % -38.73 % -99.30 % -70.97 % -97.36 % 83.31 % 154.58 % -95.72 %
From the beginning -93.16 % -82.41 % -38.73 % -99.30 % -70.97 % -97.36 % 83.31 % 154.58 % -95.72 %

Dividend